• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Logo
  • Home
  • Understanding KCNT1
  • Parents & Caregivers
    • Newly Diagnosed
    • Early-Onset KCNT1 Epilepsies
      • Medications for Early-Onset Epilepsies
    • Sleep-Related Hypermotor Epilepsy (SHE)
    • Symptoms & Treatments Overview
    • Treatment Approaches
    • Genetics 101
    • Life Expectancy & Long-Term Planning  
    • Financial & Caregiving Tools
    • Support & Resources
    • Sign Up for Our Parent Contact Form
    • Share Your KCNT1 Story
    • Find a Doctor
    • World Map (Census)
  • Professionals
    • Clinicians
    • Industry
    • Researchers
      • Biospecimens
      • KCNT1 Funding
      • Publications
  • Research & Clinical Trials
    • Parents & Caregivers
    • Clinical Trials
    • Clinical Trial Educational Resources
  • Support Us
    • Get Involved
    • Ways to Give
      • Shop our Store
      • Host a Fundraiser
  • About Us
    • Our Mission
    • Our Team
    • Our Advisors
    • Our Approach
    • Our Partners
    • Our Families
  • News & Events
    • FDA Patient Session
    • KCNT1 Remembering Day: October 21
    • News
    • Newsletter
    • KCNT1 in Orlando
    • Past Conferences
      • KCNT1 Anaheim Family Conf
      • Million Dollar Bike Ride
  • Contact
  • D♡nate

KCNT1 Global Family Map

KCNT1 World Map – Global Impact of KCNT1

Explore the global impact of KCNT1 epilepsy with our interactive world map. See where families and researchers are making a difference worldwide.

The KCNT1 Census Count

How many KCNT1 Families in the World?

KCNT1 gene variants affect people around the world. We built this map to provide a visual representation of where 493 individuals with KCNT1 gene mutations are located as of 11.5.2024. The number is over 590 now!

To add your family to this map, fill out our Family Contact form.

KCNT1 Census Count

Strength in Numbers

The KCNT1 Count is the fastest way to show potential drug developers that we have enough families to justify a drug development program for KCNT1 patients.

The more individuals with KCNT1 mutations we can document, the more attractive our rare disease is to pharmaceutical companies, biotech firms, research labs, clinicians, government funders and donors who wish to make an impact.

We invite you to take our census and join our family network. Last updated 11.5.24

Footer

fluid-image
Donate Today
  • Parents & Caregivers
  • Researchers & Professionals
  • About Us
  • Contact
  • Subscribe
Gold 2025 Candid Seal
GAA Member Badge
Citizen Health Proud Partner 2025 Website Badge

Privacy Policy

© 2023 KCNT1 Epilepsy Foundation | All Rights Reserved | Disclaimer

EIN 84-2748218

Copyright © 2026